LAMTOR5 and prostate carcinoma: Long-noncoding RNA LAMTOR5 antisense RNA 1 (LAMTOR5-AS1) has been certified as a risk predictor and diagnostic biomarker of prostate cancer and non-small cell lung cancer [34].